Millions impacted by Adderall shortage: Here’s what we know

Posted on AllSides November 17th, 2022
From The Center

Adderall, a drug commonly prescribed to treat attention deficit hyperactivity disorder (ADHD), is in short supply and people are struggling to fill their prescriptions. 

The shortage was confirmed last month by the U.S. Food and Drug Administration, which said in a statement “there is not sufficient supply to continue to meet U.S. market demand.”

Teva, the most prolific generic producer of the drug, said it has experienced ongoing intermittent manufacturing delays. The company expects the supply problems to last through March, according to a Bloomberg report.

A rise in demand...

Read full story


AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
See full bias rating for NewsNation
Learn about media bias

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right